Israeli company Kamada, which develops treatments for orphan diseases, has raised less than it aimed for on its Nasdaq IPO. The company was hoping to raise up to $69 million, but was only able to raise $51.6 million.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments